Stacy Price
Technik-/Wissenschafts-/F&E-Leiter bei INVIVYD, INC.
Vermögen: - $ am 31.05.2024
Profil
Stacy Price is currently the Chief Technology & Manufacturing Officer at Invivyd, Inc. Prior to this role, Stacy held positions as the Senior Vice President-Technical Operations at Alaunos Therapeutics, Inc. and Chief Technical Officer at Akouos, Inc. Stacy has also received undergraduate and graduate degrees from Tufts University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18.12.2023 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Stacy Price
| Unternehmen | Position | Beginn |
|---|---|---|
| INVIVYD, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 |
Ehemalige bekannte Positionen von Stacy Price
| Unternehmen | Position | Ende |
|---|---|---|
| AKOUOS | Technik-/Wissenschafts-/F&E-Leiter | - |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stacy Price
| Tufts University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
